Advertisement
YOU ARE HERE: LAT HomeCollectionsSamuel Waksal
IN THE NEWS

Samuel Waksal

FEATURED ARTICLES
BUSINESS
June 14, 2002 | WARREN VIETH, TIMES STAFF WRITER
The brother of former ImClone Systems Inc. Chief Executive Samuel D. Waksal testified Thursday that he phoned Waksal with bad news about the firm's flagship product the day before family members began dumping shares in allegedly illegal insider trading. Harlan W. Waksal, who replaced his older brother as ImClone's CEO last month, told a House subcommittee he informed Samuel Waksal on Dec.
ARTICLES BY DATE
BUSINESS
January 20, 2005 | From Associated Press
Samuel D. Waksal, the imprisoned ImClone Systems Inc. founder at the center of an insider-trading scandal that ensnared Martha Stewart, and his father have agreed to pay a total of about $5 million to resolve civil charges, regulators said. Samuel and Jack Waksal neither admitted nor denied wrongdoing in the settlement with the Securities and Exchange Commission.
Advertisement
BUSINESS
October 11, 2003 | From Reuters
The insider trading case involving former ImClone Systems Inc. Chief Executive Samuel D. Waksal and Martha Stewart has widened to include Waksal's father and sister. The Securities and Exchange Commission on Friday sued Jack Waksal, 82, in an amended complaint originally filed against Samuel Waksal. The new charges also name Samuel Waksal's sister, Patti, 47, as a relief defendant, who did not break the law but benefited from actions of her father.
BUSINESS
October 11, 2003 | From Reuters
The insider trading case involving former ImClone Systems Inc. Chief Executive Samuel D. Waksal and Martha Stewart has widened to include Waksal's father and sister. The Securities and Exchange Commission on Friday sued Jack Waksal, 82, in an amended complaint originally filed against Samuel Waksal. The new charges also name Samuel Waksal's sister, Patti, 47, as a relief defendant, who did not break the law but benefited from actions of her father.
BUSINESS
January 20, 2005 | From Associated Press
Samuel D. Waksal, the imprisoned ImClone Systems Inc. founder at the center of an insider-trading scandal that ensnared Martha Stewart, and his father have agreed to pay a total of about $5 million to resolve civil charges, regulators said. Samuel and Jack Waksal neither admitted nor denied wrongdoing in the settlement with the Securities and Exchange Commission.
NATIONAL
September 14, 2002 | From the Washington Post
Samuel and Harlan Waksal, the two brothers who ran ImClone Systems Inc., ordered shredders for the company's executive offices the day before the Securities and Exchange Commission requested corporate records in January, according to documents turned over to a congressional panel Friday. The documents do not show when the shredders arrived or whether the brothers shredded material requested by federal or congressional investigators.
BUSINESS
January 7, 2003 | From Associated Press
A federal judge threatened to force ImClone Systems Inc. founder Samuel D. Waksal to go to trial unless he and his lawyers provide personal information necessary to sentence him on his securities fraud plea. "Absolutely nothing has been provided, not even a Social Security card," Manhattan U.S. District Judge William H. Pauley said.
BUSINESS
July 31, 2002 | Reuters
Prosecutors are threatening former ImClone Systems Inc. Chief Executive Samuel D. Waksal with an unusually lengthy jail sentence amid a broad move by the government to crack down on corporate wrongdoing. Federal prosecutors are demanding that Waksal agree to seven to 10 years in prison as part of a plea bargain, according to a person familiar with the situation.
BUSINESS
October 11, 2002 | From Bloomberg News
An ImClone Systems Inc. lawyer accused company founder Samuel Waksal of forging a stock certificate 16 years ago. The allegation came in testimony Thursday before a House oversight panel investigating the handling of ImClone's cancer drug Erbitux. General counsel John Landes never notified the company's board and made the allegation for the first time before the committee. Waksal, indicted Aug.
BUSINESS
June 9, 2003 | From Reuters
Samuel D. Waksal, founder of biotech company ImClone Systems Inc., is due to be sentenced Tuesday for insider trading and may become the highest-ranking executive in the recent spate of corporate scandals to receive a prison term. Waksal, who resigned in May 2002 as chairman and chief executive of ImClone, faces a stiff fine and up to seven years in prison under federal sentencing guidelines for his role in insider trading and evading taxes on $15 million of artwork. U.S.
BUSINESS
June 9, 2003 | From Reuters
Samuel D. Waksal, founder of biotech company ImClone Systems Inc., is due to be sentenced Tuesday for insider trading and may become the highest-ranking executive in the recent spate of corporate scandals to receive a prison term. Waksal, who resigned in May 2002 as chairman and chief executive of ImClone, faces a stiff fine and up to seven years in prison under federal sentencing guidelines for his role in insider trading and evading taxes on $15 million of artwork. U.S.
BUSINESS
January 7, 2003 | From Associated Press
A federal judge threatened to force ImClone Systems Inc. founder Samuel D. Waksal to go to trial unless he and his lawyers provide personal information necessary to sentence him on his securities fraud plea. "Absolutely nothing has been provided, not even a Social Security card," Manhattan U.S. District Judge William H. Pauley said.
BUSINESS
October 11, 2002 | From Bloomberg News
An ImClone Systems Inc. lawyer accused company founder Samuel Waksal of forging a stock certificate 16 years ago. The allegation came in testimony Thursday before a House oversight panel investigating the handling of ImClone's cancer drug Erbitux. General counsel John Landes never notified the company's board and made the allegation for the first time before the committee. Waksal, indicted Aug.
NATIONAL
September 14, 2002 | From the Washington Post
Samuel and Harlan Waksal, the two brothers who ran ImClone Systems Inc., ordered shredders for the company's executive offices the day before the Securities and Exchange Commission requested corporate records in January, according to documents turned over to a congressional panel Friday. The documents do not show when the shredders arrived or whether the brothers shredded material requested by federal or congressional investigators.
BUSINESS
July 31, 2002 | Reuters
Prosecutors are threatening former ImClone Systems Inc. Chief Executive Samuel D. Waksal with an unusually lengthy jail sentence amid a broad move by the government to crack down on corporate wrongdoing. Federal prosecutors are demanding that Waksal agree to seven to 10 years in prison as part of a plea bargain, according to a person familiar with the situation.
BUSINESS
June 14, 2002 | WARREN VIETH, TIMES STAFF WRITER
The brother of former ImClone Systems Inc. Chief Executive Samuel D. Waksal testified Thursday that he phoned Waksal with bad news about the firm's flagship product the day before family members began dumping shares in allegedly illegal insider trading. Harlan W. Waksal, who replaced his older brother as ImClone's CEO last month, told a House subcommittee he informed Samuel Waksal on Dec.
BUSINESS
January 28, 2002 | DENISE GELLENE, TIMES STAFF WRITER
The highly public meltdown of ImClone Systems Inc. is casting the spotlight on Samuel Waksal, an immunologist and erstwhile film producer as comfortable with celebrities as with cells. The lanky chief executive, whose company is under investigation for allegedly misleading investors about its cancer drug, is a regular on Manhattan's social circuit, where he has been spotted with Martha Stewart, home decorating queen and mother of his former girlfriend, Alexis.
BUSINESS
April 30, 2003 | From Times Wire Services
The top two executives of ImClone Systems Inc. resigned amid federal tax and accounting investigations, the biotechnology company said late Tuesday. It is the latest blow to a company attempting to develop a breakthrough cancer drug. ImClone President and Chief Executive Harlan Waksal was asked to step down, the company said. Waksal, who served as chief operating officer before being named CEO, will remain with the company as its chief scientific officer.
BUSINESS
January 28, 2002 | DENISE GELLENE, TIMES STAFF WRITER
The highly public meltdown of ImClone Systems Inc. is casting the spotlight on Samuel Waksal, an immunologist and erstwhile film producer as comfortable with celebrities as with cells. The lanky chief executive, whose company is under investigation for allegedly misleading investors about its cancer drug, is a regular on Manhattan's social circuit, where he has been spotted with Martha Stewart, home decorating queen and mother of his former girlfriend, Alexis.
Los Angeles Times Articles
|